Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Jun;21(6):969–971. doi: 10.1128/jcm.21.6.969-971.1985

Rapid neutralization assay for human cytomegalovirus antibody.

M Zerbini, M Plazzi, M Musiani
PMCID: PMC271828  PMID: 2989327

Abstract

Human cytomegalovirus induces the appearance of immediate early antigens in infected cells 1 h after infection. This provided the basis for the development of a rapid neutralization assay for cytomegalovirus antibody which was able to yield results within a single day. Indirect immunofluorescence to visualize immediate early antigen-positive cells was applied to the rapid determination of cytomegalovirus-neutralizing antibody. The neutralization titers obtained with this assay on 92 serum samples were in accordance with the immune status as determined by enzyme-linked immunosorbent assay to cytomegalovirus-induced immediate early, early, and late antigens.

Full text

PDF
969

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gerna G., Cereda P. M., Cattaneo E., Achilli G., Revello M. G. Immunoglobulin G to virus-specific early antigens in congenital, primary, and reactivated human cytomegalovirus infections. Infect Immun. 1978 Dec;22(3):833–841. doi: 10.1128/iai.22.3.833-841.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Michelson-Fiske S., Horodniceanu F., Guillon J. C. Immediate early antigens in human cytomegalovirus infected cells. Nature. 1977 Dec 15;270(5638):615–617. doi: 10.1038/270615a0. [DOI] [PubMed] [Google Scholar]
  3. Musiani M., Carpi C., Zerbini M. Rapid detection of antibodies against cytomegalovirus induced immediate early and early antigens by an enzyme linked immunosorbent assay. J Clin Pathol. 1984 Feb;37(2):122–125. doi: 10.1136/jcp.37.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Musiani M., Zerbini M., Carpi C., Plazzi M., Sermasi G., Belletti D., Sacchi R. Serological screening for the prevention of transfusion-acquired cytomegalovirus infection. J Infect. 1984 Sep;9(2):148–152. doi: 10.1016/s0163-4453(84)91078-8. [DOI] [PubMed] [Google Scholar]
  5. Musiani M., Zerbini M. Influence of cell cycle on the efficiency of transfection with purified human cytomegalovirus DNA. Arch Virol. 1983;78(3-4):287–292. doi: 10.1007/BF01311323. [DOI] [PubMed] [Google Scholar]
  6. PLUMMER G., BENYESH-MELNICK M. A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS. Proc Soc Exp Biol Med. 1964 Oct;117:145–150. doi: 10.3181/00379727-117-29520. [DOI] [PubMed] [Google Scholar]
  7. Pereira L., Hoffman M., Gallo D., Cremer N. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun. 1982 Jun;36(3):924–932. doi: 10.1128/iai.36.3.924-932.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rundell B. B., Betts R. F. Physical properties of cytomegalorvirus immune complexes prepared with IgG neutralizing antibody, anti-IgG, and complement. J Immunol. 1980 Jan;124(1):337–342. [PubMed] [Google Scholar]
  9. Schmidt N. J., Dennis J., Lennette E. H. Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells. J Clin Microbiol. 1976 Jul;4(1):61–66. doi: 10.1128/jcm.4.1.61-66.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stalder H., Ehrensberger A. Microneutalization of cytomegalovirus. J Infect Dis. 1980 Jul;142(1):102–105. doi: 10.1093/infdis/142.1.102. [DOI] [PubMed] [Google Scholar]
  11. Stinski M. F., Mocarski E. S., Thomsen D. R. DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol. 1979 Jul;31(1):231–239. doi: 10.1128/jvi.31.1.231-239.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. The T. H., Andersen H. K., Spencer E. S., Klein G. Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clin Exp Immunol. 1977 Jun;28(3):502–505. [PMC free article] [PubMed] [Google Scholar]
  13. Waner J. L., Budnick J. E. Three-day assay for human cytomegalovirus applicable to serum neutralization tests. Appl Microbiol. 1973 Jan;25(1):37–39. doi: 10.1128/am.25.1.37-39.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zerbini M., Musiani M., Carpi C., Falcieri E. Productive and abortive replication of human cytomegalovirus at different environmental pH values. Arch Virol. 1982;72(1-2):127–131. doi: 10.1007/BF01314457. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES